Recent News

• 03.31.2025 - BioLineRx to Report 2024 Annual Results on March 31, 2025
• 03.31.2025 - BioLineRx to Report 2024 Annual Results on March 31, 2025
• 03.31.2025 - BioLineRx Reports 2024 Financial Results and Provides Corporate Update
• 03.24.2025 - BioLineRx to Report 2024 Annual Results on March 31, 2025
• 03.24.2025 - BioLineRx to Report 2024 Annual Results on March 31, 2025
• 01.21.2025 - BioLineRx Issues Letter to Shareholders
• 01.21.2025 - BioLineRx Issues Letter to Shareholders
• 01.17.2025 - BioLineRx Announces Change to Ratio of American Depositary Shares to Ordinary Shares
• 01.17.2025 - BioLineRx Announces Change to Ratio of American Depositary Shares to Ordinary Shares
• 01.17.2025 - BioLineRx Announces Change to Ratio of American Depositary Shares to Ordinary Shares

Recent Filings

• 01.21.2025 - EX-99.1 EX-99.1
• 01.21.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 01.17.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 01.10.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 01.07.2025 - 424B5 Prospectus [Rule 424(b)(5)]
• 01.07.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 01.06.2025 - EX-99.1 EX-99.1